AbbVie Inc. Equity-NMS: ABBV

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$191.22
Open :	$191.77
Today's high :	$192.1
Today's low :	$190.88
52W low :	$159.4168
52W high :	$214.8025
1Y :	2.54%
5Y :	97.92%
EPS(TTM): :	2.32
Shares O/S :	1.77 B
Market cap :	338.95 B

What is the share price of AbbVie Inc. today?

AbbVie Inc. (ABBV) share price as of July 29, 2025, is $191.22. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of AbbVie Inc.?

Yes, Indian Investors can invest in the AbbVie Inc. (ABBV) Share by opening an international trading account with Angel One.

How can I purchase AbbVie Inc. shares in India?

Purchasing AbbVie Inc. (ABBV) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying AbbVie Inc. (ABBV) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of AbbVie Inc.?

Yes, you can purchase fractional shares of AbbVie Inc. (ABBV) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of AbbVie Inc.?

The market capitalization of AbbVie Inc. on July 29, 2025, is $338.87 B.

In which sector AbbVie Inc. belongs?

AbbVie Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in AbbVie Inc. stocks?

In order to invest in AbbVie Inc. (ABBV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

AbbVie Inc. is a global, diversified research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.